We further fine-map AD risk enhancers to identify candidate functional variants that likely affect TF binding and regulate gene expression in seven loci, and validate one of these variants in the MS4A locus in human induced pluripotent stem cell (hiPSC)-derived microglia and brain. This evidence concerns the gene TF and Alzheimer disease.